Institute of Microbiology and Epizootics, Free University of Berlin, Centre for Infection Medicine, Berlin, Germany.
Microbial Technological Solutions (MTS) Ltd., Norwich, United Kingdom.
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0234421. doi: 10.1128/aac.02344-21. Epub 2022 Jun 6.
The efficacy of killing by bactericidal antibiotics has been reported to depend in large part on the ATP levels, with low levels of ATP leading to increased persistence after antibiotic challenge. Here, we show that an operon deletion strain of Salmonella enterica serovar Typhimurium lacking the ATP synthase was at least 10-fold more sensitive to killing by the fluoroquinolone antibiotic ciprofloxacin and yet showed either increased survival or no significant difference compared with the wild-type strain when challenged with aminoglycoside or β-lactam antibiotics, respectively. The increased cell killing and reduced bacterial survival (persistence) after fluoroquinolone challenge were found to involve metabolic compensation for the loss of the ATP synthase through central carbon metabolism reactions and increased NAD(P)H levels. We conclude that the intracellular ATP levels do not correlate with bactericidal antibiotic persistence to fluoroquinolone killing; rather, the central carbon metabolic pathways active at the time of challenge and the intracellular target of the antibiotic determine the efficacy of treatment.
已有研究表明,杀菌抗生素的杀菌效果在很大程度上取决于 ATP 水平,低水平的 ATP 会导致抗生素挑战后细菌的持续存在增加。在这里,我们表明,缺失 ATP 合酶的鼠伤寒沙门氏菌血清型 Typhimurium 的操纵子缺失菌株对氟喹诺酮类抗生素环丙沙星的敏感性至少增加了 10 倍,但与野生型菌株相比,当分别用氨基糖苷类或β-内酰胺类抗生素进行挑战时,其存活或无显著差异。氟喹诺酮类药物挑战后的细胞杀伤增加和细菌存活(持续存在)减少被发现涉及通过中心碳代谢反应和增加 NAD(P)H 水平对 ATP 合酶缺失的代谢补偿。我们得出结论,细胞内 ATP 水平与氟喹诺酮类药物杀菌后杀菌抗生素的持续存在无关;相反,挑战时活跃的中心碳代谢途径和抗生素的细胞内靶标决定了治疗的效果。